News Sentiment

001060 sentiment intelligence

JW Pharmaceutical Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 46 Balanced news tone 15 relevant articles
Exchange KSC South Korea
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 26700.00 Week of 19 Jun 2026
Weighted tone 46/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.3% over one week, -10.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

JW Pharmaceutical's Livalo-Zet Tops Dyslipidemia Combination Drug Market

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend inactive -10.9% over four weeks
Fair value -3.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 11
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
koreabiomed.com 6
Seoul Economic Daily 3
Business Wire 1
Pharmaceutical Technology 1
PR Newswire 1
The Korea Herald 1
Chosunbiz 1
조선일보 1

Event Lens

What the news is about

Classified themes
Market update 11
Deals and strategy 3
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15